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Abstract
Background: Studies of gene function in the mouse have relied mainly on gene targeting via
homologous recombination. However, this approach is difficult to apply in specific windows of time,
and to simultaneously knock-down multiple genes. Here we report an efficient method for dsRNA-
mediated gene silencing in late cleavage-stage mouse embryos that permits examination of
phenotypes at post-implantation stages.
Results: We show that introduction of Bmp4 dsRNA into intact blastocysts by electroporation
recapitulates the genetic Bmp4 null phenotype at gastrulation. It also reveals a novel role for Bmp4
in the regulation the anterior visceral endoderm specific gene expression and its positioning. We
also show that RNAi can be used to simultaneously target several genes. When applied to the three
murine isoforms of Dishevelled, it leads to earlier defects than previously observed in double
knock-outs. These include severe delays in post-implantation development and defects in the
anterior midline and neural folds at headfold stages.
Conclusion: Our results indicate that the BMP4 signalling pathway contributes to the
development of the anterior visceral endoderm, and reveal an early functional redundancy between
the products of the murine Dishevelled genes. The proposed approach constitutes a powerful tool
to screen the functions of genes that govern the development of the mouse embryo.
Background
Embryonic patterning in mammalian peri-implantation
development is a complex process requiring many signal-
ing events to establish the future body plan. The multiplic-
ity of isoforms of various components of these signaling
pathways makes it difficult to use classical knock-out tech-
Published: 28 December 2005
BMC Developmental Biology 2005, 5:28 doi:10.1186/1471-213X-5-28
Received: 30 July 2005
Accepted: 28 December 2005
This article is available from: http://www.biomedcentral.com/1471-213X/5/28
© 2005 Soares et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 11
(page number not for citation purposes)
BMC Developmental Biology 2005, 5:28 http://www.biomedcentral.com/1471-213X/5/28
Page 2 of 11
(page number not for citation purposes)
Effective dsRNA delivery and EGFP knock-down by electroporationFigure 1
Effective dsRNA delivery and EGFP knock-down by electroporation. (A) Representative dark-field projections of the 
rendered z-stack of x-y confocal sections of blastocysts electroporated with AF594-labelled dsRNA (540 bp) after 24 h of cul-
ture. One hundred percent of the blastocysts incorporate the dsRNA and an average of 90% of the blastomeres in each 
embryo (minimum 70%) are targeted. Left, the ICM is viewed from the top; right, the ICM is viewed laterally. (B) Representa-
tive confocal bright-field images (top) and dark-field projections of the rendered z-stack of x-y sections (bottom) of HB2-EGFP 
embryos electroporated with GFP dsRNA and LacZ dsRNA (control) at the 8-cell and blastocyst stages, followed by 24 hours 
in culture (24 AE) and in utero development until the indicated stages (E4.3 and E5.5). The reduction of GFP fluorescence inten-
sity following RNAi was similar among both the ICM cells (white arrowheads) and trophectoderm cells (red arrowhead). Like-
wise, despite the difference in fluorescence intensity between the epiblast cells and the surrounding extraembryonic tissues, 
GFP fluorescence was reduced to a similar degree in both tissues (white arrow and red arrow, respectively). (C) Average lev-
els of fluorescence intensity of the main cell lineages of GFP dsRNA-electroporated blastocysts (24 h AE), and post-implanta-
tion embryos at the indicated stages, shown as a percentage of the intensity levels of control (LacZ dsRNA-treated) embryos. 
Bar colors as follows: cultured blastocysts (n = 9): brown, ICM; dark red, trophectoderm; E4.3 and E5.5 embryos (n = 8 and n 
= 7, respectively): blue, epiblast; light blue, visceral endoderm and extraembryonic ectoderm. Note that the reduction of fluo-
rescence intensity among the different lineages at any given stage of development is very similar. Standard deviation bars are 
indicated. (D) Average GFP mRNA levels (GFP/GAP3DH ratio) of embryos electroporated with GFP dsRNA shown as a per-
centage of those of LacZ dsRNA-treated controls. Pale blue, 15 dsGFP-electroporated embryos cultured in vitro for 24 h (con-
trol embryos: 15, dark blue). Light blue, 4 and 3 dsGFP-electroporated embryos recovered at E4.3 and E5.5, respectively, 
following in utero development (control embryos: 8, dark blue). Standard deviation bars are indicated.
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arises in assessing the roles of genes required in several
different windows of developmental time. This is because
targeted deletion of genes with essential roles in develop-
ment often results in early embryonic lethality preventing
the evaluation of later functions. The use of the Cre
recombinase for temporal- and tissue-specific gene knock-
out provides one route to circumvent this problem [1].
Nonetheless, such approaches are both costly and time
consuming.
In several organisms the above difficulties have been at
least partially addressed by the use of gene silencing by
RNA interference (RNAi) [2-4]. A primary obstacle in
using RNAi in the mouse is in the delivery of dsRNA mol-
ecules into the embryo and subsequent analysis of its
development. RNAi has been employed successfully in
oocytes and early pre-implantation embryos up to the 4-
cell stage by microinjection and electroporation [5-8].
However, its application at later stages could be consid-
ered more demanding as from the 8-cell stage onwards,
some cells become internalized and therefore less accessi-
ble. Electroporation has also been used to deliver dsRNA
to post-implantation embryos ex-utero [9]. This approach
is particularly valuable for regional gene knockdown.
However, in some instances it would be useful to have the
possibility to interfere with gene expression in the whole
embryo. Transgenic expression of siRNA has also been
reported in siRNA-electroporated ES cells aggregated with
tetraploid blastomeres [10]. This approach is a valuable
way of targeting knock-down to the embryo proper, but
does not allow targeting of genes expressed in extraembry-
onic tissues such as the extraembryonic ectoderm (ExE)
and the visceral endoderm (VE) that do not arise from the
ES cell progeny. As signaling often arises in extra-embry-
onic tissues, RNAi approaches effective in such tissues
could prove very valuable.
We wished to enable studies of the effects of knocking-
down single or multiple genes simultaneously upon pat-
terning of the early post-implantation mouse embryo. To
this end we have developed a method for gene silencing
that allows dsRNA to be introduced into whole embryos
at late pre-implantation stages such that they can develop
in utero and be examined post-implantation (Additional
File 1). In developing this method we have examined the
consequences of knocking-down Bmp4 expression in spe-
cific windows of time. This revealed an unexpected contri-
bution of this signaling pathway to the development of
the anterior visceral endoderm. We then applied our
method to simultaneously knock-down the three Dishev-
elled isoforms. Our results demonstrate functional redun-
dancy between the products of these genes that when
down-regulated together have earlier effects upon devel-
opment than previously reported.
Results and Discussion
Effective EGFP knock-down by dsRNA electroporation
We first determined the most efficient conditions for the
uptake of dsRNA between the 8-cell and blastocyst stages
using labeled GFP dsRNA (540 bp) and were able to
develop parameters for electroporation of dsRNA that did
not require thinning of the zona pellucida (see Methods).
Our final method permitted uptake of dsRNA into 100%
of the electroporated embryos (n = 120). Optical section-
ing by confocal microscopy at the blastocyst stage indi-
cated that greater than 90% of the cells in each embryo
were targeted by the labeled dsRNA on average (mini-
mum 70%) (Fig. 1A).
To assess the relative efficiency of knock-down in the dif-
ferent cell lineages at both pre- and post-implantation
stages, we used a transgenic mouse line expressing the flu-
orescent fusion reporter histone (H2B)-EGFP [11]. Intact
embryos carrying the H2B-EGFP transgene, which is ubiq-
uitously expressed in a high-level constitutive manner,
were electroporated with GFP dsRNA (and LacZ dsRNA, as
a control) at the early 8-cell and blastocyst stages. Confo-
cal fluorescence microscopy following in vitro culture for
24 h showed that the delivery of the GFP dsRNA had been
equally effective in reducing the levels of H2B-EGFP fluo-
rescence in both trophectoderm and ICM lineages (Fig
1B,C). Quantification of the fluorescence intensity
revealed a 73% overall reduction of fluorescence in the
GFP dsRNA-treated embryos compared to the LacZ
dsRNA-electroporated controls (Fig. 1C). The relative
reduction of the fluorescence levels in the ICM and troph-
ectoderm cells was calculated to be of similar degree. The
overall reduction of H2B-GFP expression correlates well
with the strong knock-down at the mRNA level (80%) as
determined by RT-PCR (Fig. 1D).
Electroporated embryos were also transferred into the
uteri of pseudopregnant females and recovered and ana-
lyzed post-implantation at E4.3 and E5.5. As before, the
levels of histone-GFP fluorescence were much reduced in
GFP dsRNA-treated embryos and to a similar extent in the
different lineages of the pre-streak stage embryo. The epi-
blast, although of overall higher GFP fluorescence inten-
sity than the surrounding lineages, had its relative
fluorescence reduced to the same degree as the VE and ExE
lineages: an average 65% and 52% reduction at E4.3 and
E5.5, respectively (Fig. 1B,C). The GFP mRNA levels were
still strongly depleted at these stages despite the differ-
ences of overall fluorescence intensity being less pro-
nounced between the GFP dsRNA-treated embryos and
controls (Fig 1D). This could be explained by the stability
of the EGFP fusion protein, which remains bound to the
target even during cell division when the nuclear envelope
has broken down [11]. The reduction of H2B-GFP fluores-
cence levels induced by GFP dsRNA electroporation wasPage 3 of 11
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BMC Developmental Biology 2005, 5:28 http://www.biomedcentral.com/1471-213X/5/28Specific Bmp4 knock-down by RNAi induces a range of developmental defects post-implantationFigure 2
Specific Bmp4 knock-down by RNAi induces a range of developmental defects post-implantation. (A) RT-PCR of 
single embryos cultured in vitro for 24 h following electroporation, and embryos recovered at E5.25 and E5.75 following devel-
opment in utero. Glyceraldehyde 3-phosphate dehydrogenase (GAP3DH) was used as an internal control for cDNA loading. (B) 
Average Bmp4 mRNA levels (Bmp4/GAP3DH ratio) of embryos electroporated with Bmp4 dsRNA (dsBmp4) shown as a per-
centage of those of GFP dsRNA (dsGFP)-treated controls. Pale blue, 20 dsBmp4-electroporated embryos cultured in vitro for 
24 h (control embryos: 20, dark blue). Light blue, 10 dsBmp4-electroporated embryos recovered at E5.25 and E5.75, respec-
tively, following in utero development (control embryos: 10). Standard deviation bars are indicated. (C) Morphological pheno-
types of dsBmp4 (B-E, G-J) and control dsGFP -electroporated embryos (a, f) recovered at E6.5 and E7.5 (DIC micrographs). 
Anterior faces left when it can be identified. E6.5 and E7.5 represent the embryonic time at collection; actual embryonic stages 
may vary due to Bmp4 RNAi. dsBmp4-treated embryos are generally reduced size and acquire an abnormal round shape (c-e, 
i, j); or present gross abnormalities in (g) or lack recognizable embryonic structures (j). Some embryos show an underdevel-
oped epiblast relative to the ExE (h). The well developed ExM-derived allantois as seen in the control (f) is not normally 
observed in dsBmp4-treated embryos. Bar, 200 µm. (D) Distribution of morphological phenotypes observed past gastrulation. 
Emb. day, embryonic day; Nor, morphologically normal; Def, defective; Dl'd, delayed, Art'd, arrested. (E) Whole-mount in situ 
hybridization with anti-sense probes of indicated genes carried out on control dsGFP RNA (a-l) and dsBmp4 RNA -electropo-
rated embryos (a'-q'). The developmental stages shown represent the embryonic time at collection; actual embryonic stages 
may vary due to Bmp4 RNAi. Over 50% of the dsBmp4-electroporated embryos [developmentally delayed but otherwise nor-
mal and morphologically normal (group1)] express much reduced amounts of mesodermal Brachyury (E6.5 n = 8/15; E7.5 n = 8/
16), Eomes (E6.5 n = 5/9; E7.5 n = 4/7) and Lhx1 (E6.5 n = 3/5; E7.5 n = 3/6), suggesting that gastrulation was initiated but failed 
to continue further (a'-c', g'-h'). In contrast, all defective embryos (group2) lack expression of these genes altogether (E6.5 n = 
2, 2, 1; E7.5 n = 3, 3, 2, respectively), indicating that they failed to gastrulate (m'). The expression of visceral endoderm Cer-l, 
Lefty-1 and Lhx1 markers was also abnormal in the dsBmp4-treated embryos. While Lhx1 expression was strongly downregu-
lated in the VE of 55% of group 1 embryos (g', h') (E6.5 n = 3/5; E7.5 n = 3/6), it was completely absent in defective embryos (n 
= 3, not shown). Similarly, Lefty-1 transcripts were absent (E6.5 n = 1; E7.5 n = 2, not shown) or restricted to the DVE (E6.5 n 
= 1; E7.5 n = 2) in defective embryos (O'). In 55% of group 1 embryos (n = 11), Lefty-1 expression was found at or close to the 
DVE (f') (E6.5 n = 3/6; E7.5 n = 3/5). Accordingly, the expression of Cer-l was also found to be restricted to the DVE in all 
defective embryos essayed (n') (n = 5). In over 50% (16/31) of the embryos of group 1, the expression was either distally 
restricted and/or mislocalized, with ectopic transcripts scattered around the embryonic region in the lateral VE at both E6.5 
(d') (n = 9) and E7.5 (e') (n = 7), denoting a lack of migration of the DVE cells and ectopic expression of Cer-l. As early as E5.5 
and E5.75 the Cer-l expression domain was extended towards both anterior and posterior regions of the VE overlying the epi-
blast (k', p') (n = 8); restricted distally (l') (n = 2) or absent q' (n = 3) in a total of 16 embryos. Red arrows show the midline of 
the anterior-posterior axis of the embryo; black arrows delimitate the boundaries of Cer-l expression in the VE. Bmp4 expres-
sion in the ExE was already detectable by E6.5 in dsBmp4-electroporated embryos (i'). Epiblast Oct4 expression was normal at 
both E6.5 (j') and E7.5 (not shown). Anterior faces left when it can be identified, except in d' where both lateral (L) and ante-
rior (A) views are presented. Bar, 200 µm.
actually surprisingly high for a highly expressed protein onic regions of the conceptus [16]. After gastrulation,
product that starts being expressed at the 4-cell stage and,
because of its inherent stability, persists in the cells for
long periods of time.
Bmp4 knock-down recapitulates null phenotype and 
reveals new Bmp4 function
To further study the role of key signaling pathways in peri-
implantation development, we chose to target the endog-
enous mouse gene Bmp4, a member of the TGF-β super-
family of secreted signaling molecules [12]. We wished to
determine whether electroporation of pre-implantation
embryos with Bmp4 dsRNA led to similar phenotypes,
specifically in events around the time of gastrulation, as
reported for the genetic loss of its function [13-15]. Bmp4
is first expressed in the ICM and polar trophectoderm of
the embryonic day 3.5 (E3.5) blastocyst. As the embryo
develops to E6.5 its expression becomes restricted to the
ExE and is highest in the cells abutting the epiblast close
to the boundary between the embryonic and extraembry-
Bmp4 is expressed in epiblast-derived tissues, including
the extraembryonic mesoderm [15].
We introduced Bmp4 dsRNA into intact E3.5 blastocysts
by electroporation and first determined the efficiency of
knock-down by measuring the Bmp4 expression levels 24
h and 48 h later by RT-PCR. Bmp4 mRNA was reduced in
Bmp4 dsRNA-electroporated embryos at both 24 h (Fig
2A,B) and 48 h after electroporation (not shown), com-
pared to the GPF dsRNA-electroporated experimental
controls. Levels of Gap3dh (Fig 2A) and Stat3 mRNA (not
shown) were unaffected, suggesting that the Bmp4 dsRNA
electroporation resulted in sequence-specific knock-down
of Bmp4 expression. Electroporated embryos were trans-
ferred into the uteri of pseudopregnant females and then
recovered and analyzed at several stages post-implanta-
tion. Bmp4 expression was reduced by as much as 70% at
E5.25 and 44% at E5.75, as determined by RT-PCR (Fig
2A,B). The Bmp4 dsRNA-electroporated embryos dis-Page 5 of 11
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Bmp4 null embryos many of which arrest in development
shortly after implantation, but a proportion showing
some development to later stages [13]. Between E6.5 and
E7.5, and at some later stages, 46% (n = 255) of Bmp4
dsRNA-electroporated embryos were reduced in size by at
least 30%. They were also rounded, disorganized or
necrotic, and had underdeveloped epiblasts (Fig 2C). This
contrasted with the 1% (n = 202) of control embryos that
were slightly delayed in development, but morphologi-
cally normal, demonstrating that the long dsRNA has a
specific effect and that, in accordance to other reports,
does not elicit non-specific responses at these stages [7,9].
At E7.5 Bmp4 dsRNA-electroporated embryos also lacked
or had a reduced mesoderm-derived allantois (Fig 2C,
panel g).
Bmp4 is required for epiblast cell proliferation, mesoderm
formation [13,14] and has been suggested to promote dif-
ferentiation of the VE [16]. We therefore examined the
expression of a set of molecular markers of the prospective
mesoderm (Brachyury, Eomes, Lhx1) and visceral endo-
derm (Cer-l, Lefty-1, Lhx1) at E6.5 and E7.5 following
Bmp4 RNAi. Brachyury, Eomes and posterior Lhx1 expres-
sion was absent in all defective embryos. It was also
absent or significantly reduced in over 52% of the remain-
ing group of Bmp4 dsRNA-electroporated embryos that
appeared morphologically normal, whether delayed in
development or not (Fig 2E, panels a'-c', g', h', and Addi-
tional File 1). This reduced expression of mesoderm mark-
ers suggests that in some embryos primitive streak
formation and the initiation of gastrulation probably
occurred but failed to progress further. It is consistent with
the reported phenotypes of Bmp4-/- embryos [13].
The consequences for the expression of markers of the
anterior VE (AVE) were less expected. Before gastrulation,
by E5.5, Cer-l and Lefty-1 transcripts are normally
restricted to the distal tip of the VE (DVE). These DVE cells
then move towards the prospective anterior of the embryo
and so by E6.0 become the AVE that plays a key role in
anterior patterning [17,18]. We found that the expression
of Cer-l was abnormal in Bmp4 dsRNA-electroporated
embryos already at E5.5 and E5.75 (Fig 2E and Additional
File 1). In a small number of embryos (3/16) we were
unable to detect Cer-l transcripts at these stages (Fig 2E,
panel q'). Rather than being slightly shifted towards the
prospective anterior at E5.5 [18], we found that in 50% of
Bmp4 dsRNA-treated embryos (n = 8/16), the Cer-l
expressing domain was expanded symmetrically around
the distal tip towards both the anterior and posterior
regions of the VE (Fig 2E, panels k', p'). Between E6.5 and
E7.5, Cer-l expression was either abolished or localized to
the distal tip in all morphologically defective embryos.
Moreover, in 52% (n = 16/31) of the remaining group of
dsBmp4-treated embryos of normal morphology we
observed an extensive diffuse region of ectopic Cer-l
expression around the DVE and in the lateral VE (Fig 2E,
panels d'-e'). Lefty-1 expression had a similar pattern to
that of Cer-l in all defective embryos at these stages, as well
as in 55% (6/11) of the remaining Bmp4 dsRNA-treated
embryos, although no ectopic transcripts were observed
(see Additional File 1). Lhx1, which was expressed
throughout the AVE in the control embryos, was downreg-
ulated in 55% of the Bmp4 dsRNA-electroporated
embryos (n = 6/11), thus confirming a disruption of AVE
patterning.
Thus, our results indicate that down-regulation of Bmp4
expression changes the AVE expression domain. The
expression of DVE markers either remains distal (Cer-l
and Lefty-1) or spreads laterally (Cer-l). This suggests that
Bmp4 signals that mainly originate from the ExE at these
and earlier stages can regulate the restriction of the AVE
expression domain and its specific positioning. This pat-
tern of regulation is in agreement with a report that
showed that BMP signaling promotes differentiation of
VE in embryoid bodies [16]. It is also consistent with the
phenotype of the BMP antagonists Chordin and Noggin
double mutants, which fail to maintain expression of Cer-
l at E7.5 [19], supporting the role of Bmp4 in regulating
Cer-l.
Our results also indicate that the effects of Bmp4 in pat-
terning the VE occur in a time window between E3.5 and
E5.5. We observed that a proportion of embryos can
"recover" from the transient nature of the knock-down
during the course of the experiment, as determined by RT-
PCR at E5.75 (Fig 2B) and at E6.5 by in situ hybridization
(Fig 2E, panel i'). The transient nature of the RNAi effect
can be seen as an advantage in a given experimental con-
text, as it enables the period of gene expression required
for events relating to embryo patterning to be pin-
pointed. The definition of time intervals in which essen-
tial signaling molecules are required is critical for the
understanding of the AVE specification and subsequent
migration. Thus the approach we propose here might
prove very valuable in addressing AVE function as it
allows modulating gene expression just after embryo
implantation.
Aside from these novel findings, the other phenotypes fol-
lowing Bmp4RNAi are strikingly similar to those reported
for null mutant embryos both in form and variability.
Approximately 20% of embryos developed to E9.5, albeit
with severe defects [13]. In all, over 70% of the embryos
were either morphologically abnormal and/or defective in
the expression of essential mesoderm and VE markers fol-
lowing Bmp4 RNAi. It cannot be excluded that some part
of the observed pleiotropy may be attributed to differen-Page 6 of 11
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with the H2B-GFP transgenic embryos indicate that all
cell lineages are targeted by the dsRNA to a very similar
extent.
Simultaneous knock-down of the three murine 
Dishevelled genes
We next wished to determine whether this approach could
enable functional redundancy between genes to be exam-
ined. To this end, we simultaneously targeted the three
murine Dishevelled (Dvl1–3) genes [20-22]. The Dishev-
elled proteins are members of the Wnt developmental
pathway, which regulates cell fate and subsequent cell
behaviour in metazoans [23]. Analysis of the genetic null
mutants (single and double mutants) has suggested
redundancy of function among these genes [24-26]. To
our knowledge a triple genetic knockout of these genes
has not been reported, perhaps due to the difficulty of
generating such a mutant. Although the three isoforms are
expressed throughout pre-implantation development, a
significant increase in expression is seen from the morula
stage onwards, which is shared by a number of Wnt family
members [27]. Thus, to ensure effective knock-down of all
three Dvl genes we subjected embryos to co-electropora-
tion with the corresponding three dsRNAs at two succes-
sive stages. The first treatment was given to 8-cell stage
embryos and was followed by a second treatment when
the embryos had developed to the blastocyst stage. A sig-
nificant knock-down of the Dvl mRNA levels (average
70% Dvl1, 76% Dvl2 and 73% Dvl3) was observed 24 h
(Fig 3A) and 48 h (not shown) after each electroporation
treatment. We also electroporated each Dvl dsRNA inde-
pendently and found that the mRNA knock-down
achieved was similar to that observed upon co-electropo-
ration of the three Dvl simultaneously (n = 10 for each
Dvl).
Following a period of development in utero, the embryos
were recovered and analyzed at E6.5 and E7.5 or E8.0.
While the embryos treated with a single Dvl dsRNA did
not shown any morphological abnormalities at these
stages (for each Dvl: n = 14, E6.5 and n = 15, E7.5+), nearly
half (42/89) of the Dvl1–3 dsRNA-electroporated embryos
were severely retarded in development or showed mor-
phological abnormalities (Fig 3B,C). Forty percent of the
affected embryos had not gastrulated as assessed by mor-
phological analyses (Fig. 3B, panel g). In contrast, only 2
of 72 dsGFP-electroporated control embryos were devel-
opmentally delayed but showed no apparent defects.
Interestingly, approximately 12% (n = 65) of the Dvl1–3
dsRNA-treated embryos examined at E8.0 showed a
grossly distorted anterior midline and neural fold abnor-
malities. These were developmentally retarded and had a
sinuous or bent anterior axial mesendoderm, which
seemed to be connected anteriorly to a single neural fold
of either side (Fig 3B, panel c-e). These defects appear to
represent an earlier onset of the later neural tube closure
phenotype observed in Dvl1-/-; Dvl2-/- double mutants
[25]. Unexpectedly, neither the expression of mesodermal
markers Brachyury, Eomes, and Lhx1, the VE markers Cer-l
and Lhx1, nor the epiblast marker Oct4 appeared to be
abnormal in a set of developmentally delayed embryos
following dsDvl1–3 dsRNAi (Fig 3D). This indicates that
while the knock-down of Dvl was effective in the
"delayed" embryos – and enough to cause developmental
delays – it was not sufficient to prevent gastrulation, such
as observed for the group of morphologically defective
embryos. The failure to gastrulate observed in the latter set
of embryos upon Dvl1–3 RNAi is in agreement with the
role of the Wnt signaling pathway in primitive streak for-
mation, as typified by the Wnt3 mutants and Lrp5-/-;Lrp6-/
- double mutants [28,29].
It is possible that the observed pleiotropy of the pheno-
type following Dvl down-regulation can be attributed to
differential uptake of dsRNA. Based on the relative kinet-
ics of EGFP and Bmp4 knock-down, it seems likely that the
efficacy of knock-down and the rate of mRNA recovery are
target dependent. Thus, factors such as the level of expres-
sion, turnover rate of mRNA species, and protein product
stability/degradation might dictate the extent of the RNAi
phenotype.
Our results have shown novel phenotypes following
down-regulation of specific genes and so demonstrate
that electroporation of pre-implantation embryos with
single or multiple dsRNAs directed against genes encod-
ing related proteins is effective.
Conclusion
In this paper we describe a novel function for Bmp4 in reg-
ulating the development of the anterior-posterior axis:
Bmp4 knock-down perturbs the specific positioning of the
AVE and may induce ectopic expression of Cer-l in the lat-
eral and posterior VE of the embryo. The simultaneous
knock-down of all three Dvl isoforms leads to earlier
defects in development than those reported for double
knockout mutants. This indicates an early functional
redundancy between these genes. The method we describe
here enables the functional study of single or multiple
genes within a specific window of developmental time. It
offers a relatively rapid approach to assay gene function in
the peri-implantation period of development.
Methods
dsRNA preparation
RNAs were in vitro transcribed from PCR-generated tem-
plates using the Ribomax Large-Scale RNA Production
System (Promega, Southampton, UK). Chimeric primers
containing the T7 promoter sequence and gene-specificPage 7 of 11
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Dvl1 (nt 960–1406, 446 bp), Dvl2 (nt 864–1393, 547 bp),
Dvl3 (nt 1479-1061, 418 bp), GFP (nt 98–638, 540 bp),
and LacZ (521 bp) templates. In vitro transcription reac-
tions and subsequent DNAse treatment and RNA purifica-
tion were performed according to the manufacturer's
instructions. The purified RNA was denatured at 70°C for
10 min and let anneal at RT for several hours. The quality
and concentration of dsRNA were determined by gel elec-
trophoresis and spectrophotometry. For electroporation,
dsRNA was diluted in chilled hepes buffered saline (HBS)
to a concentration of 2 mg/ml (dsBmp4, dsDvl1, dsDvl2,
Specific Dvl1–3 knockdown induces developmental delays post-implantation, and anterior midline and neural fold defectsFigure 3
Specific Dvl1–3 knockdown induces developmental delays post-implantation, and anterior midline and neural 
fold defects. (A) Average Dvl1–3 mRNA levels (Dvl1–3/GAP3DH ratio) of 10 embryos electroporated with dsDvl1–3 shown as a 
percentage of those of 10 dsGFP-treated controls, following 24 h in culture. Standard deviation bars are indicated. (B) Morpho-
logical phenotypes of dsDvl1–3 (c-g) and control dsGFP -electroporated embryos (a, b) recovered at E7.5 and E8.0 (brightfield 
micrographs). Anterior faces left when it can be identified, except in b-e, where an anterior view is presented. E7.5 and E8.0 
represent the embryonic time at collection; actual embryonic stages may vary due to Dvl RNAi. dsDvl1–3-treated embryos are 
smaller than normal and retarded in development (c-f) (compare with f in Fig 2C, note scale bars). Note the severe delay in f 
and the early developmental arrest in g. Notably, in some E8.0 embryos, the anterior midline was grossly distorted and, in 
some cases, was connected anteriorly to a single neural fold of either side (d, e), giving to the anterior view the appearance of 
a slightly-lateralized view. Bar, 200 µm. (C) Distribution of morphological phenotypes observed past gastrulation. Emb. day, 
embryonic day; Nor, normal; Def, defective; Dl'd, delayed, Art'd, arrested. (D) Whole-mount in situ hybridization with anti-
sense probes of indicated genes on dsDvl1–3-electroporated embryos. Anterior faces left. Expression of Brachyury (n = 10), 
Eomes (n = 8), Lhx1 (n = 8), Cer-l (n = 11) and Oct4 (n = 6) is seemingly unaffected in these embryos (compare to Fig 2e, top 
row). Note the severe developmental delay, particularly evident in b, f and h, and the abnormal extraembryonic region in h. 
Bar, 200 µm.Page 8 of 11
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trol for the co-electroporation of the three dsDvl).
dsRNA labelling
RNAs were in vitro transcribed as described above in a 100
µl reaction according to the manufacturer instructions but
with 75 mM aminoallyl-UTP (Sigma). Following anneal-
ing, the dsRNA was passed through BioRad P30 Micro-
Biospin columns (BioRad, Hemel Hempstead, UK)
previously buffer-exchanged to 100 mM NaHCO3
(pH7.5), and mixed at RT, dark O/N with 33 µl of 10 mg/
ml Alexa Fluor 594-succinimidyl ester (Molecular Probes)
in DMSO. After phenol/chloroform extraction and iso-
propanol precipitation, the dsRNA was further purified
through BioRad P30 MicroBiospin columns (10 mM Tris
pH7.4) and an additional phenol/chloroform and isopro-
panol step.
Embryo collection and culture
All experimental procedures with live animals were con-
ducted in accordance with UK Government Home Office
Licensing regulations. Embryos were collected from F1
(C57BL/6 × CBA) superovulated females crossed with F1
males or transgenic histone H2B-GFP males [11]. Supero-
vulation was carried out by intraperitoneal injection of 10
IU of pregnant mare serum gonadotrophin (PMSG, Folli-
gon, Intervet) followed by 10 IU of human chorionic
gonadotrophin (hCG, Corulon, Intervet) 46–48 h later.
Fertilized embryos were collected 64–68 h (8-cell stage),
76–78 h (16-cell stage) and 88–90 h (blastocysts) post
hCG injection. Collection was performed in M2 medium
containing 4 mg/ml bovine serum albumin (BSA) and
culture in KSOM supplemented with 4 mg/ml BSA, at
37°C under 5% CO2.
Electroporation and uterine transfer
The embryos were electroporated in a flat electrode cham-
ber (1 mm gap between electrodes) (BTX inc., San Diego,
CA) in 50 µl of dsRNA solution in HBS. Electric pulses
were delivered using a 2001 Electro Cell Manipulator
(BTX inc., San Diego, CA) as follows: 3 sets of 4 pulses of
1 ms at 28–30 V, with 1 minute interval between sets and
inverting polarity. Following electroporation, the
embryos were cultured in KSOM for subsequent uterine
transfer or RT-PCR. After a minimum of 2 hours in cul-
ture, the embryos were transferred into pseudo-pregnant
F1 females, which had been mated 2.5 days before with
vasectomized F1 males. Five embryos were introduced per
uterus.
RT-PCR
One to ten embryos were washed in PBS and lysed in TRI-
zol (Invitrogen, Paisley, UK) 24 h and 48 h after electro-
poration. Total RNA was isolated and retro-transcribed by
standard procedures. PCR amplification was performed
with the following primers: Bmp4 (5'-TGGACTGTTAT-
TATGCCTT-3'; 5'-GGAGATCACCTCATTTTCTGG-3');
Dvl1 (5'-CATCCTCCTTCAGCAGCATCAC-3'; 5'-ACTCG-
TACCATAGCGGGGC-3'); Dvl2 (5'-AGACTCGGATGAG-
GATGACA-3'; 5'-AAGGCTCCAGTCAGCGCA-3'); Dvl3
(5'-TGGGGCTGTGGCAGCTGATGG-3'; 5'-GAGGCCAT-
GGCTTTTACGATG); GFP (5'-ACGTAAACG-
GCCACAAGTTC-3'; 5'-GTTGGGGTCTTTGCTCAGG-3');
and GAPDH (5'-GCATGGACTGTGGTCATGAG-3'; 5'-
CCATCACCATCTTCCAGGAG-3'). For each gene, the PCR
parameters were optimized to detect differences in mRNA
levels: Bmp4 (39 cycles E3.5, 43 cycles E5.25/E5.75, 60°C
annealing), Dvl1 (42 cycles, 55°C annealing), Dvl2 (38
cycles, 55°C annealing), Dvl3 (46 cycles, 60°C anneal-
ing), GFP (32 cycles, 60°C annealing) and GAP3DH (27
cycles, 60°C annealing). PCR products were electro-
phoresed in 2.0% agarose gels with ethidium bromide,
photographed under UV light and quantified using The
Discovery Series Quantity One 1-D Analysis Software Ver-
sion 4.4.1 (BioRad).
Whole-mount in situ hybridization
Embryos recovered at E5.5, E5.75, E6.5 and E7.5 and dis-
sected free of maternal tissues and Reichert's membrane
were fixed in 4% paraformaldehyde in PBS for at least 24
h. Noon on the day of plug is E0.5. Whole mount in situ
hybridization was performed as described http://
www.hhmi.ucla.edu/derobertis/protocol_page/
mouse.PDF. Control and experimental embryos were
processed simultaneously and developed for the same
time length.
Imaging
For confocal imaging, the embryos were placed between
two coverslips with a petroleum jelly seal in droplets of
M2 medium (blastocysts) or DMEM medium supple-
mented with 45% human cord serum (post-implantation
embryos). To increase adhesion, slides were previously
treated with poly-L-lysine (Sigma) for 5 minutes.
Laser scanning confocal data was taken using 20× air
objective lenses on an inverted Nikon microscope with a
BioRad MCR scanning head. Images were acquired as z-
stacks comprising sequential x-y sections taken at 2–4 µm
z-intervals. Raw data was processed and quantified using
Volocity (Improvision).
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Figure 1. Method for RNAi in peri-implantation development. Sche-
matic representation of the proposed method for transient loss of gene 
function by electroporation followed by uterine transfer and development 
in utero. Approaches for the assessment of gene-specific knock-down and 
phenotypic analyses are suggested. Table 1. Proportion of dsBmp4 RNA-
electroporated embryos with defective expression of indicated marker 
genes. Group 1, embryos morphologically normal (MN) and developmen-
tally delayed or arrested (DA); group 2, morphologically defective embryos 
(Df). SExp, symmetrically expanded expression around the distal tip; DR, 
distally (DVE) restricted expression; Abs, absence of expression.
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